144 related articles for article (PubMed ID: 28748604)
21. Current perspective on pediatric pharmacogenomics.
Abaji R; Krajinovic M
Expert Opin Drug Metab Toxicol; 2016; 12(4):363-5. PubMed ID: 26799591
[No Abstract] [Full Text] [Related]
22. Institutional profile: University of Florida and Shands Hospital Personalized Medicine Program: clinical implementation of pharmacogenetics.
Johnson JA; Elsey AR; Clare-Salzler MJ; Nessl D; Conlon M; Nelson DR
Pharmacogenomics; 2013 May; 14(7):723-6. PubMed ID: 23651020
[TBL] [Abstract][Full Text] [Related]
23. Progressing the utilisation of pharmacogenetics and pharmacogenomics into clinical care.
Trent RJ; Cheong PL; Chua EW; Kennedy MA
Pathology; 2013 Jun; 45(4):357-70. PubMed ID: 23594690
[TBL] [Abstract][Full Text] [Related]
24. Applying Multiplex Assays to Understand Variation in Pharmacogenes.
Chiasson M; Dunham MJ; Rettie AE; Fowler DM
Clin Pharmacol Ther; 2019 Aug; 106(2):290-294. PubMed ID: 31145826
[No Abstract] [Full Text] [Related]
25. Challenges in Ordering and Interpreting Pharmacogenomic Tests in Clinical Practice.
Moyer AM; Rohrer Vitek CR; Giri J; Caraballo PJ
Am J Med; 2017 Dec; 130(12):1342-1344. PubMed ID: 28757317
[No Abstract] [Full Text] [Related]
26. The Advantages and Challenges of Diversity in Pharmacogenomics: Can Minority Populations Bring Us Closer to Implementation?
Zhang H; De T; Zhong Y; Perera MA
Clin Pharmacol Ther; 2019 Aug; 106(2):338-349. PubMed ID: 31038731
[TBL] [Abstract][Full Text] [Related]
27. Review on Pharmacogenetics and Pharmacogenomics Applied to the Study of Asthma.
Sánchez-Martín A; García-Sánchez A; Isidoro-García M
Methods Mol Biol; 2016; 1434():255-72. PubMed ID: 27300544
[TBL] [Abstract][Full Text] [Related]
28. PGX: Pharmacogenomics During Generation X.
Yee J
Adv Chronic Kidney Dis; 2016 Mar; 23(2):57-60. PubMed ID: 26979142
[No Abstract] [Full Text] [Related]
29. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
30. Pharmacogenomic Challenges in Cardiovascular Diseases: Examples of Drugs and Considerations for Future Integration in Clinical Practice.
Chatelin J; Stathopoulou MG; Arguinano AA; Xie T; Visvikis-Siest S
Curr Pharm Biotechnol; 2017; 18(3):231-241. PubMed ID: 28117005
[TBL] [Abstract][Full Text] [Related]
31. Pharmacogenomics in Critical Care.
Cheek D; Howington L
AACN Adv Crit Care; 2018; 29(1):36-42. PubMed ID: 29496712
[TBL] [Abstract][Full Text] [Related]
32. Personalized pharmacogenomics profiling using whole-genome sequencing.
Mizzi C; Peters B; Mitropoulou C; Mitropoulos K; Katsila T; Agarwal MR; van Schaik RH; Drmanac R; Borg J; Patrinos GP
Pharmacogenomics; 2014 Jun; 15(9):1223-34. PubMed ID: 25141897
[TBL] [Abstract][Full Text] [Related]
33. Pharmacogenomics and implementation of precision therapeutics in the neonatal ICU: a new frontier?
Lewis T; Leeder JS
Pharmacogenomics; 2018 Nov; 19(16):1231-1233. PubMed ID: 30334480
[No Abstract] [Full Text] [Related]
34. Race, distributive justice and the promise of pharmacogenomics: ethical considerations.
Lee SS
Am J Pharmacogenomics; 2003; 3(6):385-92. PubMed ID: 14672519
[TBL] [Abstract][Full Text] [Related]
35. Pharmacogenomics and pharmacogenetics. 1st Spanish Congress on Pharmacogenomics and Pharmacogenetics, January 23-25, 2005, Valencia, Spain.
Iqbal O
Pharmacogenomics; 2005 Apr; 6(3):205-7. PubMed ID: 16013951
[No Abstract] [Full Text] [Related]
36. Pharmacogenomics of GPCR Drug Targets.
Hauser AS; Chavali S; Masuho I; Jahn LJ; Martemyanov KA; Gloriam DE; Babu MM
Cell; 2018 Jan; 172(1-2):41-54.e19. PubMed ID: 29249361
[TBL] [Abstract][Full Text] [Related]
37. Pharmacogenomics and personalized medicine in clinical practice.
Manolopoulos VG; Dechairo B; Huriez A; Kühn A; Llerena A; van Schaik RH; Yeo KT; Ragia G; Siest G
Pharmacogenomics; 2011 May; 12(5):597-610. PubMed ID: 21619425
[TBL] [Abstract][Full Text] [Related]
38. Next generation sequencing: implications in personalized medicine and pharmacogenomics.
Rabbani B; Nakaoka H; Akhondzadeh S; Tekin M; Mahdieh N
Mol Biosyst; 2016 May; 12(6):1818-30. PubMed ID: 27066891
[TBL] [Abstract][Full Text] [Related]
39. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
40. En route to precision medicine through the integration of biological sex into pharmacogenomics.
Gaignebet L; Kararigas G
Clin Sci (Lond); 2017 Feb; 131(4):329-342. PubMed ID: 28159880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
